Xtant Medical Holdings XTNT Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 62.3%-0.6pp | 62.9%+0.9pp | 62%+1.9pp | 60.2%+2.0pp | 58.2%0.0pp | |
| Net margin | 1.5%-2.2pp | 3.7%+2.4pp | 1.3%+4.9pp | -3.6%+6.2pp | -9.8%+4.2pp | |
| EBITDA margin | 9.2%-2.6pp | 11.8%+3.6pp | 8.2%+4.7pp | 3.5%+6.2pp | -2.7%+4.0pp | |
| Free cash flow margin | 6.4%-1.2pp | 7.6%+3.7pp | 3.9%+6.1pp | -2.2%+5.5pp | -7.7%+6.0pp | |
| Returns | ||||||
| Return on equity | 3.9%-6.6pp | 10.6%+6.9pp | 3.6%+13.4pp | -9.8%+16.4pp | -26.2%+8.7pp | |
| Return on assets | 2.1%-3.2pp | 5.3%+3.6pp | 1.7%+6.3pp | -4.6%+8.0pp | -12.6%+5.0pp | |
| Return on invested capital | 5.8%-7.7pp | 13.5%+5.4pp | 8%+8.0pp | 0%+12.3pp | -12.3%+7.2pp | |
| Efficiency | ||||||
| Asset turnover | 1.4×0.0× | 1.4×+0.1× | 1.3×0.0× | 1.3×0.0× | 1.3×0.0× | |
| Inventory turnover | 1.3×-0.1× | 1.4×+0.2× | 1.2×0.0× | 1.3×-0.1× | 1.3×0.0× | |
| Liquidity | ||||||
| Current ratio | 3.3×+0.7× | 2.7×+0.4× | 2.2×-0.3× | 2.5×+0.1× | 2.3×0.0× | |
| Quick ratio | 1.6×0.0× | 1.6×+0.6× | 1.1×-0.1× | 1.2×+0.1× | 1×0.0× | |
| Cash ratio | 0.6×+0.1× | 0.6×+0.3× | 0.3×+0.1× | 0.2×0.0× | 0.2×0.0× | |
| Leverage | ||||||
| Debt-to-equity | 0.3×0.0× | 0.4×-0.1× | 0.4×-0.1× | 0.5×0.0× | 0.5×0.0× | |
| Debt-to-assets | 0.2×0.0× | 0.2×0.0× | 0.2×0.0× | 0.2×0.0× | 0.2×0.0× | |
| Net debt / EBITDA | 0.3×+0.2× | 0×-0.9× | 1×-3.0× | 4×— | —— | |
| Interest coverage | 2×-0.8× | 2.9×+1.3× | 1.6×+1.5× | 0×+1.7× | -1.7×+1.2× | |
| Per Share | ||||||
| Book value per share | $0.35+2.2% | $0.34+1.4% | $0.34+2.6% | $0.33+6.6% | $0.31-4.8% | |
| Valuation | ||||||
| Market capitalization | $59.05M-32.5% | $109.76M+20.8% | $90.85M+2.5% | $88.61M+35.6% | $65.36M+6.1% | |
| Enterprise value | $61.89M-41.5% | $110.3M+8.8% | $101.38M-4.9% | $106.64M+28.5% | $82.96M+5.8% | |
| Price / earnings | 32.3×— | 22.1×-29.8× | 51.9×— | —— | —— | |
| Price / sales | 0.5×-0.2× | 0.8×+0.1× | 0.7×0.0× | 0.7×+0.2× | 0.5×0.0× | |
| Price / book | 1.2×-0.6× | 2.2×+0.4× | 1.8×0.0× | 1.8×+0.3× | 1.5×+0.1× | |
| EV / EBITDA | 5.4×-17.7× | 7×-2.3× | 9.3×-14.4× | 23.7×— | —— | |
| EV / sales | 0.5×-0.3× | 0.8×+0.1× | 0.8×-0.1× | 0.8×+0.2× | 0.7×0.0× | |
| Free cash flow yield | 13.4%+16.7pp | 9.3%+3.6pp | 5.7%+8.9pp | -3.2%+11.2pp | -14.4%+11.6pp | |
| Earnings yield | 3.2%+8.5pp | 4.5%+2.6pp | 1.9%+7.1pp | -5.2%+13.2pp | -18.3%+8.4pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Xtant Medical Holdings's profit margins?
- Xtant Medical Holdings (XTNT) runs a 62.3% gross margin and a 4.8% operating margin, with a 1.5% net margin.
- Where do Xtant Medical Holdings's ratios come from?
- Every ratio is computed from Xtant Medical Holdings's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
